Showing results (1-10 of 686) with videos related to
Sort By:
Pageof 69
Pharmacogenetics|April 1, 1993
Carbonyl (phenone) reductase in human liver: inter-individual variabilityJ M Wong, W Kalow, D Kadar, et al.Research Communications in Chemical Pathology and Pharmacology|May 1, 1981
Antipyrine metabolites in two populationsT Inaba, H Uchino, D Kadar, et al.British Journal of Clinical Pharmacology|April 1, 1985
Genetic polymorphism of mephenytoin p(4')-hydroxylation: difference between Orientals and CaucasiansM Jurima, T Inaba, D Kadar, et al.Clinical Pharmacology and Therapeutics|August 1, 1983
Variation in amobarbital metabolism: evaluation of a simplified population studyB K Tang, W Kalow, T Inaba, et al.Clinical Pharmacology and Therapeutics|November 1, 1978
Distinctive patterns of amobarbital metabolitesW Kalow, B K Tang, D Kadar, et al.Clinical Pharmacology and Therapeutics|May 1, 1977
A case of deficiency of N-hydroxylation of amobarbitalW Kalow, D Kadar, T Inaba, et al.Canadian Journal of Physiology and Pharmacology|September 1, 1980
Ethnic difference in drug metabolism: debrisoquine 4-hydroxylation in Caucasians and OrientalsW Kalow, S V Otton, D Kadar, et al.Clinical Pharmacology and Therapeutics|December 1, 1980
Acute and latent leukopenic reaction to antipyrineD Kadar, W KalowClinical Pharmacology and Therapeutics|November 1, 1975
Salivary excretion of amobarbital in manT Inaba, W KalowCanadian Journal of Physiology and Pharmacology|April 1, 1983
The fate of orally administered [4-14C]phenytoin in two healthy male volunteersD Kadar, T D Fecycz, W KalowPageof 69